Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.85 USD | -2.71% | -7.93% | +73.75% |
08/05 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
07/05 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.75% | 53Cr | |
+8.29% | 11TCr | |
+10.21% | 11TCr | |
+0.41% | 2.23TCr | |
-11.90% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.17% | 1.72TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- HC Wainwright Lowers Price Target on Y-mAbs Therapeutics to $11 From $19, Maintains Buy Rating